Harbour Investments Inc. Grows Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Harbour Investments Inc. increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 30.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,972 shares of the financial services provider’s stock after acquiring an additional 465 shares during the period. Harbour Investments Inc.’s holdings in iShares Biotechnology ETF were worth $261,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in IBB. Darwin Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $29,000. HHM Wealth Advisors LLC boosted its position in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after buying an additional 150 shares during the period. Bradley & Co. Private Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $32,000. Newbridge Financial Services Group Inc. purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $33,000. Finally, Hager Investment Management Services LLC purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $133.58 on Friday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The business has a 50 day simple moving average of $136.23 and a two-hundred day simple moving average of $139.39. The firm has a market capitalization of $6.09 billion, a PE ratio of 27.83 and a beta of 0.77.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were paid a dividend of $0.1212 per share. The ex-dividend date of this dividend was Tuesday, March 18th. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.